Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Eppendorf is launching the new VisioNize® box 2,
The journey and merging of sperm and egg cells is
This year, the Hamburg based life sciences company
Alembic Pharmaceutica
Since it’s an ingredient in so many foods, you h
In a world constantly in motion, Microbioz India r
AstraZeneca Plc said on Friday clinical trials of its experimental COVID-19 vaccine declared in Japan, while adding that it was in talks with regulators on data necessary to restart studies in the United States, where they remain halted.
Several global trials of the vaccine, AZD1222, were put on hold last month after an unexplained illness in a study participant. Although most trials have resumed, U.S. trials continue to be on pause as regulators widened their probe, Reuters reported on Wednesday.
While most trials have resumed, U.S. trials are still on pause as regulators widened their probe, Reuters reported on Wednesday.
The British drugmaker said the early-to-mid-stage trial for the vaccine candidate against the novel coronavirus resumed in Japan after consultations with the federal health regulator, the Japanese Pharmaceuticals and Medical Devices Agency.
Trials in Britain, Brazil, South Africa and India had already declared.
